A case of coronavirus disease 2019 in a pregnant woman successfully treated with shoseiryuto: A telephone consultation

A case of coronavirus disease 2019 in a pregnant woman successfully treated with shoseiryuto: A telephone consultation
复制标题

2019年冠状病毒病孕妇使用shoseiryuto成功治疗的一例:电话咨询

DOI:
10.1002/tkm2.1350
复制
发表时间:
2022
期刊:
Traditional & Kampo Medicine
影响因子:
--
通讯作者:
Nakae Hajime
Nakae Hajime
中科院分区:
--
文献类型:
--
作者:
Tanaka Hidenori;Miura Hiroshi;Terada Yukihiro;Nakae Hajime

文献摘要

参考文献

相似文献

尊敬的编辑先生2019冠状病毒病(COVID-19)在日本的病例数已达到2100万,并正在上升; COVID-19疫情正在继续恶化和缓解。COVID-19病例的激增将给全国各地的医院带来压力;我们估计,所有感染中约有0. 5%可能发生在怀孕期间。妊娠晚期的所有感染都会增加早产的可能性,并可能导致严重疾病[1]。口服药物,如莫努匹拉韦,不能开处方,因为它们的致畸潜力[2],降低孕妇疾病严重程度的药物有限。汉方药物有效,相对便宜,并且对于偶发病毒感染是安全的,但是只有少数用于治疗孕妇的汉方药物的病例被报道[3]。我们经历了一例COVID-19持续症状的病例,包括一名孕妇的咳嗽。一名产妇在怀孕30周零一天时患上了COVID-19,并选择了家庭护理。她的同居丈夫和两岁的儿子分别在她发病前10天和6天感染了COVID-19。由于持续咳嗽和痰,影响了她的睡眠,她通过秋田市公共卫生中心向我们诊所提出了电话咨询的要求。我们处方Shoseiryuto(SST)(Tsumura医用提取物),7.5 g/d,共5天。治疗后,她的咳嗽和痰几乎完全缓解(表1),并将其剩余病情的管理转移到她计划分娩的医院。
Dear Editor The number of coronavirus disease2019 (COVID-19) cases in Japan has reached 21 million and is rising; the COVID-19 epidemic is continuing with exacerbations and remissions. The surge in COVID-19 cases will put a strain on hospitals across the country; we estimate that approximately 0.5% of all infections may occur during pregnancy. All infection during late pregnancy increases the probability of preterm delivery and may cause severe illness [1]. Oral drugs, like molnupiravir, cannot be prescribed because of their teratogenic potential [2], and drugs reducing the disease severity in pregnant women are limited. Kampo medicines are effective, relatively inexpensive, and safe for incident viral infections, but only a few cases of Kampo medicines used to treat pregnant women have been reported [3]. We experienced a case of COVID-19 with persistent symptoms, including cough in a pregnant woman.A primiparous woman developed COVID-19 at 30weeks and one day of gestation and opted for home care. Her, cohabiting husband and two-year-old son had COVID-19 ten and six days respectively before her illness set in. Because of persistent cough and phlegm that disturbed her sleep at night, she made a request for a telephone consultation from our clinic through the Akita City Public Health Center. We prescribed shoseiryuto (SST)(a Tsumura medical extract), 7.5 g/d for fivevdays. After treatment, her cough and sputum were alleviated almost fully (Table 1), and management of her remaining condition was transferred to the hospital at which she was scheduled for delivery.
DOI: 10.1142/u034
发表时间: 2020
期刊: Traditional & Kampo Medicine
影响因子: --
作者:
Zhongjing Zhang;Aiyun Liu;Chouping Han
通讯作者: Chouping Han